Kroger Specialty Pharmacy Recalls Revlimid Capsules Due to Processing Controls
Kroger Specialty Pharmacy is recalling Revlimid 25 mg oral capsules due to a lack of processing controls. The affected lots were dispensed between December 2017 and February 2018.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
Kroger Specialty Pharmacy, Inc. is recalling Revlimid 25 mg oral capsules (NDC 59572-0425-21, 28-day supply) because of a lack of processing controls. The recall covers all lots remaining within their expiry date that were dispensed between December 1, 2017, and February 12, 2018.
The affected products were distributed in Mississippi, Louisiana, Arkansas, Illinois, and Florida. The U.S. Food and Drug Administration has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. No specific illnesses or injuries have been reported in the source text.
The recalled product
- Product
- Revlimid 25 mg oral cap NDC 59572-0425-21 28 days supply
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
- Category
- Drug — Oral Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Distribution
Part of a larger recall action
This product is one of 67 recalled by Kroger Specialty Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same manufacturer · Kroger Specialty Pharmacy, Inc.
See all →- HighKroger Recalls Botox Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Capecitabine Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cimzia 200 mg/mL PFS Kits
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Lupron Depot Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cyclophosphamide Capsules Due to Processing Controls
FDA (Drugs) · 2018-05-16
Same hazard · processing defect
See all →- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Products
USDA FSIS · 2023-12-07
- HighUndercooked Ready-to-Eat Stuffed Chicken Product Subject to Public Health Alert
USDA FSIS · 2023-02-03
- SevereWayne Farms Recalls Undercooked Ready-to-Eat Chicken Breast Fillets
USDA FSIS · 2022-04-29
- ModerateMasterPharm Recalls Sildenafil Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05